Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoadsorption--a new therapeutic possibility for multiple sclerosis?

J M Schneidewind, R Winkler, W Ramlow

    Transfusion Science
    |February 6, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report.

    Atherosclerosis·2024
    Same author

    Coherent control of rare earth 4f shell wavefunctions in the quantum spin liquid Tb<sub>2</sub>Ti<sub>2</sub>O<sub>7</sub>.

    Nature communications·2024
    Same author

    Origin of Pinning Disorder in Magnetic-Field-Induced Wigner Solids.

    Physical review letters·2024
    Same author

    Fractional Quantum Hall State at Filling Factor ν=1/4 in Ultra-High-Quality GaAs Two-Dimensional Hole Systems.

    Physical review letters·2024
    Same author

    Highly Anisotropic Even-Denominator Fractional Quantum Hall State in an Orbitally Coupled Half-Filled Landau Level.

    Physical review letters·2023
    Same author

    Valley-Tunable Even-Denominator Fractional Quantum Hall State in the Lowest Landau Level of an Anisotropic System.

    Physical review letters·2023

    Protein A immunoadsorption offers significant improvement for chronic progressive multiple sclerosis patients. This treatment provides stable neurological and functional gains with manageable frequency, unlike plasma exchange.

    Area of Science:

    • Neurology
    • Immunology

    Background:

    • Multiple Sclerosis (MS) is a chronic, progressive neurological disease.
    • Conservative treatments for MS can lead to complications.
    • Plasma exchange (PLEX) was initiated due to complications from conservative MS management.

    Observation:

    • PLEX initially improved Kurtzke Expanded Disability Status Scale (EDSS) scores in an MS patient.
    • Treatment intervals for PLEX progressively shortened over time.
    • A transition to Protein A immunoadsorption was considered due to PLEX limitations.

    Findings:

    • Protein A immunoadsorption demonstrated good and stable improvement in neurological status.
    • Functional status also showed sustained improvement with Protein A immunoadsorption.
    • The treatment frequency for Protein A immunoadsorption was acceptable at once every 3 weeks.

    Related Experiment Videos

    Implications:

    • Protein A immunoadsorption presents a viable therapeutic option for progressive MS.
    • This treatment may offer a more sustainable alternative to plasma exchange for certain MS patients.
    • Further research into immunoadsorption therapies for MS is warranted.